VedPred: Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab

Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab: this retrospective study validated two clinical decision support tools (CDSTs) for predicting effectiveness of vedolizumab in IBD patients with real world data from a Dutch hospital. The CDST predicted clinical, composite and steroid-free remission and adherence after 54 weeks well in patients with ulcerative colitis, but not in patients with Crohn's disease. Therefore, the CDST seems especially useful for choice of therapy in ulcerative colitis.

Data en bronnen

Deze gegevensset heeft geen inhoud

Extra Informatie

Veld Waarde
Titel VedPred: Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab
Omschrijving

Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab: this retrospective study validated two clinical decision support tools (CDSTs) for predicting effectiveness of vedolizumab in IBD patients with real world data from a Dutch hospital. The CDST predicted clinical, composite and steroid-free remission and adherence after 54 weeks well in patients with ulcerative colitis, but not in patients with Crohn's disease. Therefore, the CDST seems especially useful for choice of therapy in ulcerative colitis.
Keywords
Contact points
Contact point 1
URI
Naam
Wetenschapsbureau MMC
Name (translations)
Email
wetenschapsbureau@mmc.nl
Identifier
URL
    Publisher
    Publisher 1
    URI
    Naam
    Máxima Medical Centre
    Name (translations)
    Email
    wetenschapsbureau@mmc.nl
    URL
    http://www.mmc.nl
    Type
    Publisher note
    Publisher type
    Identifier
    https://ror.org/02x6rcb77
    Creator
    Creator 1
    URI
    Naam
    Máxima Medical Centre
    Name (translations)
    Email
    wetenschapsbureau@mmc.nl
    URL
    http://www.mmc.nl
    Type
    Publisher note
    Publisher type
    Identifier
    https://ror.org/02x6rcb77
    Landing page
    Release date
    Modification date
    In Series
      Versie
      Version notes
      Identifier https://doi.org/10.3390/pharmaceutics18010015
      Frequency
      Provenance
      Type
      Temporal coverage
      Temporal resolution
      Spatial coverage
      Spatial resolution in meters
      Access rights http://publications.europa.eu/resource/authority/access-right/RESTRICTED
      Other identifier
      Theme
      1. http://publications.europa.eu/resource/authority/data-theme/HEAL
      Taal
      1. http://id.loc.gov/vocabulary/iso639-1/en
      Documentation
      Conforms to
      Is referenced by
      Distribution
      Sample
      Analytics
      Applicable legislation
      1. http://data.europa.eu/eli/reg/2025/327/oj
      Has version
      Code values
      Coding system
      Purpose
      Health category
      Health theme
      Legal basis
      Minimum typical age
      Maximum typical age
      Number of records
      Number of records for unique individuals.
      Personal data
      Publisher note
      Publisher type
      Trusted Data Holder
      Population coverage
      Retention period
      Health data access body
      Qualified relation
      Provenance activity
      Qualified attribution
      Attribution 1
      Agent
      Agent 1
      URI
      Naam
      Luc Derijks
      Name (translations)
      Email
      l.derijks@mmc.nl
      URL
      http://www.mmc.nl
      Homepage
      Type
      Identifier
      https://orcid.org/0000-0002-6038-9295
      Rol
      https://standards.iso.org/iso/19115/resources/Codelists/gml/CI_RoleCode.xml#principalInvestigator
      Quality annotations
      URI https://fdp-acc.healthdata.nl/dataset/daecd721-3e26-4699-8d73-f02510a75f52